Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Interim analysis of CALGB 150607: A pilot study of the mutational & expression status of MET, HGF, EGFR, KRAS, p53, c-CBL, and E-cadherin in resected lung adenocarcinoma specimens Proceeding/Conference:Clinical Cancer Research | 2012 | ||
A Phase II study of dasatinib in patients with chemo-sensitive relapsed small cell lung cancer (SCLC): CALGB 30602 Proceeding/Conference:Journal of Thoracic Oncology | 2009 | ||
Validation of the CALGB and EORTC Prognostic Models for Mesothelioma based on multiple CALGB Trials (Alliance) Proceeding/Conference:Journal of Thoracic Oncology | 2013 |